| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | -0.6% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | — |
| Gross margin | 13.1% | Net margin 14.8% |
| Revenue Q/Q | -1.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 86.9% |
| R&D | ¥0.01B | 2.7% |
| SG&A | ¥0.03B | 12.3% |
| Tax & other | ¥0.01B | 4.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
国瑞科技 ・ 康泰生物 ・ 飞荣达 ・ 立昂技术 ・ 长川科技 ・ 恒锋信息 ・ 金太阳 ・ 拓斯达 ・ 思特奇 ・ 汇纳科技 ・ 晨化股份 ・ 美力科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies